Method for producing and purifying sodium hyaluronate cationic quaternary ammonium salt in a homogeneous medium
A homogeneous reaction between sodium hyaluronate and 2,3-epoxypropyltrimethylammonium chloride in a HMF-water solvent system addresses the inefficiencies of existing methods, achieving a high grafting ratio and reducing environmental impact while simplifying the production and purification of cationic sodium hyaluronate.
Patent Information
- Application Number
- JP2023065503
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2022-11-18
- Filing Date
- 2023-04-13
- Publication Date
- 2024-11-11
- Estimated Expiration
- 2043-04-13
AI Technical Summary
Existing methods for producing cationic sodium hyaluronate suffer from non-uniform grafting rates, low reaction conversion, and environmental pollution due to the use of heterogeneous reactions and excessive salt addition, leading to product aggregation and inefficient purification.
A method involving a homogeneous reaction between sodium hyaluronate and 2,3-epoxypropyltrimethylammonium chloride in a solvent mixture of HMF and water, without added salt, using a basic catalyst to achieve a high grafting ratio of 0.69, and a purification process that includes alcohol precipitation and salt removal.
The method achieves a high grafting ratio of 0.69, reduces product aggregation, simplifies the production process, and minimizes environmental impact by eliminating the need for excessive salt, facilitating easy purification and scalability.
Smart Images

Figure 0007580143000001 
Figure 0007580143000002 
Figure 0007580143000003
Abstract
Description
[Technical field]
[0001] The present invention relates to the technical field of producing cationic hyaluronate salts, in particular to a method for producing and purifying cationic quaternary ammonium salt of sodium hyaluronate in a homogeneous medium. [Background technology]
[0002] Cationic surfactants have excellent disinfection and sterilization, anticorrosion and antistatic properties, and also have emulsifying and wetting properties, and can be used for medical disinfection and sterilization, and are also useful as waterproofing agents, and are widely used in the pharmaceutical, energy, chemical, food, detergent, printing and other industries. Quaternary ammonium salts have poor cleaning power but strong disinfection and sterilization power, and most of the cationic surfactants are quaternary ammonium salts, which are the most widely produced and have a wide range of uses.
[0003] The carboxyl functional group of sodium hyaluronate is negatively charged, and the surface of the human body is also negatively charged, so that hyaluronic acid products generally have poor absorption effect on the surface of the human body, and are easily washed off with water, which affects the moisturizing effect of the product. If hyaluronic acid has cations, it can greatly improve the adhesion of the product to the skin surface, improve the shortcoming of hyaluronic acid's poor moisturizing ability, and thereby develop skin care beauty products that can efficiently moisturize and are easily absorbed by the skin surface of the human body. The synthesis of cationic sodium hyaluronate can greatly improve the emulsifying and moisturizing function of sodium hyaluronate, and is expected to be applied in many fields such as medicine, beauty, and cosmetics.
[0004] In the prior art, most patents adopt the reaction of hyaluronic acid (salt) with water / ethanol and their mixed solution, and in the method for producing cationic sodium hyaluronate, all of them use the mixture of water and organic solvent as a medium to react hyaluronic acid (salt) with cationization reagent; for example, China Patent Application Publication No. 111560086 describes a method for producing cationic hyaluronate salts by semi-dry method, but in the process of producing cationic sodium hyaluronate by semi-dry method, the grafting rate is not uniform, and the molecules inside the solid particles cannot carry out effective cationic grafting. China Patent Application Publication No. 101316864 produces cationic sodium hyaluronate in a solvent where sodium hyaluronate and water coexist, but due to the poor solubility of raw materials, the reaction conversion rate is low, and it takes a long reaction time to obtain the target product. In addition, some patents use a mixed solvent of water and ethanol, and in order to increase the solubility of sodium hyaluronate in an alcohol / water system, it is necessary to add a large amount of edible salt to the reaction system to increase the ionic strength, which results in a complicated process of removing the salt, which interferes with the post-treatment process and causes unnecessary pollution to the environment. In the method for preparing cationized hyaluronic acid or its salt in the specification of China Patent Application Publication No. 101715457, the ionization process uses a heterogeneous reaction, and not only is the ionization rate of the cation low, but the ionization is not uniform; in order to increase the solubility of hyaluronic acid in the solution, a large amount of sodium chloride solution (usually the amount of salt added is 1-5%) needs to be added during the reaction to increase the ionic strength of the system, and further increase the solubility of hyaluronic acid in the system; thus, a large amount of salt is encapsulated in the precipitated product, which increases the number of washings and discharges a large amount of wastewater; and sodium hyaluronate in a non-uniform medium is prone to aggregation, so that when the sodium hyaluronate product encapsulating salt is applied to hair improvement agents, stratum corneum repair agents, skin improvement agents, and cosmetics, it is prone to aggregation phenomenon, which affects the use of the product. In addition, the addition of salt solution also greatly hinders the recovery of the solvent by post-treatment, which not only takes time and effort, but also leads to resource waste and environmental pollution.In addition, in this scheme, the reaction between sodium hyaluronate and cationization reagent occurs at the carboxyl group site, and the measurement of the substitution degree of cationic sodium hyaluronate indicates the number of moles of active carboxyl group substituted per mole of monomer. From this, theoretically, the maximum substitution degree is 1. As the substitution degree increases, the viscosity and transparency of the reaction solution improve, and when a base is added, the cleavage of cationic etherification reagent is promoted in the early stage of the reaction, and the reaction with sodium hyaluronate is promoted, but in the later stage of the reaction, the molecular chain of cationic sodium hyaluronate is cut by the base, which inhibits the progress of the reaction, and the longer the molecular chain of sodium hyaluronate, the more difficult the substitution reaction becomes. As the substitution degree continues to increase, the water solubility of cationic sodium hyaluronate is increasingly improved, the swelling in water becomes intense, and the elongation range of the molecule becomes larger, which also brings about a tendency that the cationization degree and yield of cationic sodium hyaluronate are balanced within a certain range. Summary of the Invention [Problem to be solved by the invention]
[0005] In response to the above problems existing in the prior art, the present invention provides a method for producing and purifying cationic quaternary ammonium salt of sodium hyaluronate in a homogeneous medium, which obtains a graft product in which 2,3-epoxypropyltrimethylammonium chloride is grafted onto the oxygen atom of hydroxymethyl of sodium hyaluronate, and makes the graft rate of the product as high as 0.69 while avoiding the need to add salt during the reaction, and effectively avoids the phenomenon of product aggregation. [Means for solving the problem]
[0006] The technical solutions used by the present invention to solve the above technical problems are as follows:
[0007] In one aspect, the present invention provides a method for producing a method for treating a cancer cell comprising: The present invention provides a method for producing and purifying sodium hyaluronate cationic quaternary ammonium salt in a homogeneous medium, which comprises the steps of: adding a homogeneous solvent and sodium hyaluronate (HA) solid (the sodium hyaluronate used is high molecular weight sodium hyaluronate with a molecular weight of 1,000,000 to 1,200,000 Dal) to a vessel, heating the mixture until it dissolves into a homogeneous system, adding an aqueous solution of 2,3-epoxypropyltrimethylammonium chloride (GTA), then adding a basic catalyst, and stirring at a predetermined temperature to carry out a grafting reaction, thereby obtaining a graft product in which 2,3-epoxypropyltrimethylammonium chloride is bonded to the oxygen atom of the alkyl hydroxy of sodium hyaluronate. No salt is added during the grafting reaction, and the synthesis route is shown below. [ka]
[0008] Furthermore, the homogeneous solvent is at least one of HMF, DMF, ethanol, methanol, acetic acid, and DMSO, or a mixture of these with water.
[0009] Furthermore, the homogeneous solvent is a mixture of HMF and H2O, HMF-H2O. Preferably, in the HMF-H2O, HMF (formamide) is 50% by volume to 80% by volume of water (HMF / H2O, v / v).
[0010] Furthermore, the molar ratio of the solid sodium hyaluronate to 2,3-epoxypropyltrimethylammonium chloride is 1:0.5-10, preferably 1:2.
[0011] Furthermore, the predetermined temperature is 40 to 80° C., and the reaction time is at least 1 hour.
[0012] Furthermore, the basic catalyst is at least one of NaOH, KOH, Na2CO3, K2CO3, CH3COONa, CH3COOK, KHCO3, and NaHCO3. The molar ratio of the basic catalyst to HA is in the range of 0.2 to 1.0, and within this range, the degree of cationization is high, preferably 1:1. If the amount of the basic catalyst is too large, side reactions will increase.
[0013] Furthermore, a method for producing and purifying sodium hyaluronate cationic quaternary ammonium salt in a homogeneous medium comprises: After the grafting reaction is completed, the reaction system is subjected to alcohol precipitation to obtain a mixed solution A containing a precipitate, and the separated precipitate is added to water to dissolve it sufficiently to obtain a liquid material; A step of adding 1-5% purified salt NaCl or KCl solution (as a swelling inhibitor) to the liquid material, stirring to dissolve it sufficiently, and adjusting the pH value of the liquid material to 6.0-7.5, the salt added in this step can be removed in the subsequent water washing process to eliminate the salt content of the product; performing a secondary alcohol precipitation, adding water to the separated precipitate to further dissolve it, and performing a further alcohol precipitation to obtain a precipitate; The method further includes the steps of washing the precipitate with alcohol, dehydrating and drying to obtain the final product.
[0014] Furthermore, in alcohol precipitation, the volume ratio of the liquid material to ethanol is 1:1-10, and when water is added to the precipitate to dissolve it, the mass / volume ratio of the precipitate to water is 1:5-50.
[0015] In another aspect, the present invention provides a cationic quaternary ammonium salt of sodium hyaluronate prepared by the above-mentioned method, the structural formula of which is shown below: [ka] Effect of the Invention
[0016] The beneficial effects of the present invention are as follows: 1. In the present invention, by chemically modifying HA molecules in a homogeneous medium, positively charged quaternary ammonium groups are grafted onto the oxygen atoms of the hydroxymethyl groups in the sodium hyaluronate molecules, giving the entire molecule a certain degree of positive electrical properties, and the positive and negative charges attract each other, so that the modified sodium hyaluronate quaternary ammonium salt derivatives can be well adsorbed onto the surface of hair and skin, and have good moisturizing and moisturizing properties. At the same time, the quaternary ammonium base has a hydrophilic trimethylammonium chloride group, so it has strong hydrophilicity. Due to the remarkable molecular properties of the sodium hyaluronate molecules grafted with quaternary ammonium bases, they exhibit excellent moisturizing and moisturizing properties in hair washing and hair care products and cleansing cosmetics. 2. In the present invention, by using homogeneous reaction, under the condition of adding less or no salt, the product can obtain a higher grafting rate, and at the same time, in this embodiment, the aggregation of sodium hyaluronate can be effectively reduced by washing out the existing salt with water. The preparation method is simple and easy to operate, the cationization process avoids adding a large amount of salt, the purification of the product is simple, and it is easy to scale up. 3. The present invention further employs a specific homogeneous solvent, HMF-H2O system, which acts as a grafting reaction solvent between HA and GTA, in which the homogeneous system is formed such that the ratio of HMF in the homogeneous system is 50% by volume to 80% by volume (HMF / H2O, v / v). The inventors have surprisingly found that in this solvent system, the cationization grafting efficiency is significantly improved compared to other alcohols or solvents such as DMF and DMSO, and the specific grafting ratio can reach 0.69, which is a significant advance over the prior art. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0017] The following describes the principles and features of the present invention, but the examples given are merely illustrative of the invention and are not intended to limit the scope of the invention.
[0018] Example 1 The method for preparing and purifying sodium hyaluronate cationic quaternary ammonium salt in this embodiment includes the following steps: 1000ml of 50% by volume HMF-H2O solution was added to a three-neck flask equipped with a stirrer and reflux condenser, stirred and preheated to 65°C in a water bath. 50g of sodium hyaluronate solid powder with a molecular weight of 1.36MDa was weighed, and the solid powder was slowly added to the preheated HMF solvent while stirring. Next, 0.42g of sodium hydroxide and a solution of 40g of 2,3-epoxypropyltrimethylammonium chloride dissolved in 200ml of water (HA / GTA molar mass ratio = 1:2) were added in sequence, and the reaction mixture was stirred in a water bath at 65°C for 4.0h. 2000ml of 90% ethanol was added to precipitate a solid precipitate. The precipitate was collected by filtration, deionized purified water was added, stirred, and the precipitate was fully dissolved, and 2% of the purified NaCl salt solution was added to the liquid material after dissolution, the pH of the liquid material was adjusted to 6.8 using a dilute hydrochloric acid solution, and 1x ethanol was added to the volume to precipitate. After precipitation, the mixture was left to stand for 0.5 hours, the supernatant alcohol was removed, the precipitate was further dissolved in deionized purified water, and a secondary precipitation was carried out by adding 1x the volume of ethanol. After the secondary precipitation, the top layer of alcohol was removed and the precipitate was washed with 60% ethanol. The washed precipitate was dehydrated with absolute ethanol, and the dehydrated material was left to stand for 1 hour, then dried in a vacuum drying box for 6 hours to obtain 47.6 g of the cationized product. Upon detection, the white solid powder had a loss on drying of 3.68%, a graft ratio of 0.66, a pH of 6.8, a protein residue of 0.04%, and an ignition residue of 3.2%.
[0019] Example 2 The method for preparing and purifying sodium hyaluronate cationic quaternary ammonium salt in this embodiment includes the following steps: 1000ml of 80% by volume HMF aqueous solution was added to a three-neck flask equipped with a stirrer and a reflux condenser, and the HMF solution in the flask was heated to 40°C in a water bath. 50g of sodium hyaluronate solid powder with a molecular weight of 1.36MDa was weighed out, and the solid powder was slowly added to the preheated HMF solvent while stirring. Next, a solution of potassium hydroxide (0.42g) and 2,3-epoxypropyltrimethylammonium chloride (40g) dissolved in 200ml of water (HA / GTA molar mass ratio = 1:2) was added in sequence, and the reaction mixture was stirred at 40°C for 6.0h. 2000ml of 90% ethanol was added to precipitate a solid precipitate. The precipitate was collected by filtration, deionized purified water was added, stirred, and the precipitate was fully dissolved, and 1% purified NaCl solution was added to the dissolved liquid material, the pH of the liquid material was adjusted to 6.0 to remove chloride ions, and 1x ethanol was added to the volume to precipitate. After precipitation, the mixture was left to stand for 0.5 hours, and the supernatant alcohol was removed. The precipitate was further dissolved in deionized purified water, and then a secondary precipitation was carried out by adding 1x the volume of ethanol. After the secondary precipitation, the top layer of alcohol was removed and the precipitate was washed with 60% ethanol. The washed precipitate was dehydrated with absolute ethanol, and the dehydrated material was left to stand for 1 hour, then dried in a vacuum drying box for 6 hours to obtain 47.9 g of the cationized product. Upon detection, the white solid powder had a drying loss of 4.47%, a graft conversion of 0.69, a pH of 6.8, a protein residue of 0.04%, and an ignition residue of 3.9%.
[0020] Example 3 The method for preparing and purifying sodium hyaluronate cationic quaternary ammonium salt in this embodiment includes the following steps: 1000 ml of 60% HMF aqueous solution (HMF / H2O, v / v) was added to a three-neck flask equipped with a stirrer and reflux condenser, and the reaction mixture was stirred in a water bath and preheated to 80 °C. 50 g of sodium hyaluronate solid powder with a molecular weight of 1.36 MDa was weighed out, and the solid powder was slowly added to the preheated HMF aqueous solution while stirring. Next, a solution of sodium carbonate (0.42 g) and 2,3-epoxypropyltrimethylammonium chloride (40 g) dissolved in 200 ml of water (the molar ratio of HA to GTA is 1:2) was added in sequence, and the reaction mixture was stirred at 80 °C for 3.0 h. 2000 ml of 90% ethanol was added to precipitate a solid precipitate. The precipitate was collected by filtration, deionized purified water was added, and the precipitate was thoroughly dissolved by stirring. 4% purified saline was added to the liquid material after dissolution, the pH value of the liquid material was adjusted to 6.5, and 1 volume of ethanol was added to precipitate the liquid material. After precipitation, the mixture was left to stand for 0.5 hours, and the supernatant alcohol was removed. The precipitate was further dissolved in deionized purified water, and then a secondary precipitation was carried out by adding 1x the volume of ethanol. After the second precipitation, the top layer of alcohol was removed and washed with 60% ethanol. The washed precipitate was dehydrated with absolute ethanol, and the dehydrated material was left to stand for 1 hour, then dried in a vacuum drying box for 6 hours to obtain 47.2 g of product. Upon detection, the white solid powder had a loss on drying of 4.98%, a graft ratio of 0.63, a pH of 6.8, a protein residue of 0.03%, and a residue on ignition of 3.2%.
[0021] Example 4 The method for preparing and purifying sodium hyaluronate cationic quaternary ammonium salt in this embodiment includes the following steps: 1000ml of 60% HMF aqueous solution was added to a three-neck flask equipped with a stirrer and reflux condenser, and the reaction mixture was stirred in a water bath and preheated to 80℃. 50g of sodium hyaluronate solid powder with a molecular weight of 1.36MDa was weighed out, and the solid powder was slowly added to the preheated HMF solvent while stirring. Next, a solution of potassium acetate (0.42g) and 2,3-epoxypropyltrimethylammonium chloride (40g) dissolved in 200ml of water (HA to GTA molar ratio of 1:2) was added in sequence, and the reaction mixture was stirred at 80℃ for 1.2h. 2000ml of 90% ethanol was added to precipitate a solid precipitate. The precipitate was collected by filtration, deionized purified water was added, stirred, and the precipitate was fully dissolved, 5% purified saline was added to the dissolved liquid material, the pH value of the liquid material was adjusted to 6.5, and 1 volume of ethanol was added to precipitate it. After precipitation, the mixture was left to stand for 0.5 hours, and the supernatant alcohol was removed. The precipitate was further dissolved in deionized purified water, and then a secondary precipitation was carried out by adding 1x the volume of ethanol. After the second precipitation, the top layer of alcohol was removed and washed with 60% ethanol. The washed precipitate was dehydrated with absolute ethanol, and the dehydrated material was left to stand for 1 hour, then dried in a vacuum drying box for 6 hours to obtain 47.3 g of product. Upon detection, the white solid powder had a loss on drying of 4.57%, a graft ratio of 0.63, a pH of 6.8, a protein residue of 0.03%, and an ignition residue of 3.3%.
[0022] Comparative Example 1 Except for changing the HMF-H2O solution as the solvent to a 40% by volume HMF-H2O solution, the method for producing and purifying the sodium hyaluronate cationic quaternary ammonium salt of this comparative example was almost the same as that of Example 1. 44.0 g of product was obtained. Upon detection, the white solid powder had a loss on drying of 3.84%, a graft ratio of 0.35, a pH of 6.7, a protein residue of 0.04%, and an ignition residue of 4.3%.
[0023] Comparative Example 2 Except for changing the HMF-H2O solution as the solvent to a 90% by volume HMF-H2O solution, the method for producing and purifying the cationic quaternary ammonium salt of sodium hyaluronate in this comparative example was almost the same as that in Example 1. 43.5g of product was obtained. Upon detection, the white solid powder had a loss on drying of 3.93%, a graft ratio of 0.30, a pH of 6.8, a protein residue of 0.04%, and an ignition residue of 2.7%.
[0024] Comparative Example 3 Except for changing the solvent from HMF-H2O solution to DMF-H2O solution, the method for producing and purifying sodium hyaluronate cationic quaternary ammonium salt in this comparative example was almost the same as that in Example 1. 42.1 g of product was obtained. Upon detection, the white solid powder had a loss on drying of 5.67%, a graft ratio of 0.18, a pH of 6.8, a protein residue of 0.02%, and an ignition residue of 2.3%.
[0025] Comparative Example 4 Except for changing the HMF-H2O solution to DMSO, the method for producing and purifying the cationic quaternary ammonium salt of sodium hyaluronate in this comparative example was almost the same as that in Example 1. 43.1 g of the product was obtained. Upon detection, the white solid powder had a loss on drying of 6.78%, a graft ratio of 0.27, a pH of 6.9, a protein residue of 0.02%, and an ignition residue of 2.4%.
[0026] Comparative Example 5 Except for changing the HMF-H2O solution to ethanol (heterogeneous system), the method for producing and purifying the sodium hyaluronate cationic quaternary ammonium salt in this comparative example was almost the same as in Example 1. 42.6 g of the product was obtained. Upon detection, the white solid powder had a loss on drying of 4.26%, a graft ratio of 0.22, a pH of 6.8, a protein residue of 0.02%, and a residue on ignition of 3.1%.
[0027] Comparative Example 6 Except for the mass molar ratio of HA to GTA being 1:0.5, the method for producing and purifying sodium hyaluronate cationic quaternary ammonium salt in this comparative example was almost the same as that in Example 1. 43.87 g of product was obtained. Upon detection, the white solid powder had a loss on drying of 4.13%, a graft ratio of 0.34, a pH of 6.8, a protein residue of 0.04%, and an ignition residue of 2.7%.
[0028] Comparative Example 7 Except for the mass molar ratio of HA to GTA being 1:0.2, the method for producing and purifying sodium hyaluronate cationic quaternary ammonium salt in this comparative example was almost the same as that in Example 1. 40.9 g of product was obtained. Upon detection, the white solid powder had a loss on drying of 4.56%, a graft ratio of 0.08, a pH of 6.8, a protein residue of 0.03%, and an ignition residue of 2.9%.
[0029] The quaternary ammonium salt of hyaluronic acid produced by the above-mentioned method of the present invention is ionized and is mainly grafted onto the oxygen atom of hydroxymethyl of hyaluronic acid molecule, and the grafting rate (substitution degree) is calculated by purifying cationic hyaluronic acid product by methanol Soxhlet extraction, and calculating the nitrogen content in cationic hyaluronic acid by Kjeldahl method.Substitution degree (DS) is calculated from the nitrogen content.
number
[0030] In the above formula, W1 is the percentage nitrogen content of the measured cationic quaternary ammonium salt of hyaluronate (measured by the Kjeldahl method), W0 is the percentage nitrogen content of the raw hyaluronate (measured by the Kjeldahl method), and M S is the molar mass of the sodium hyaluronate unit, 379 g / mol, and M GTA is the relative molecular mass of GTA, 151.6 g / mol, and 1400 is the unit converted value for the relative molecular weight of the nitrogen atom. The graft ratio data for the above examples and comparative examples are shown in Table 1.
[0031] [Table 1]
[0032] From the data of the above examples and comparative examples, it can be seen that the present invention uses 50% HMF-80% HMF aqueous solution as a reaction solvent, and compared with other conventional reaction solvents, no salt is added during grafting reaction, and the product obtained has a significantly better grafting rate. When the molar ratio of sodium hyaluronate solid, basic catalyst, and 2,3-epoxypropyltrimethylammonium chloride is 1:1:2, good yield and cationization degree can be obtained.
[0033] 50% HMF-80% HMF aqueous solution has the highest solubility for sodium hyaluronate, and can completely dissolve sodium hyaluronate at 65℃ with a dissolving power of 1.0-2.0g / 100mL. As a result of cationic grafting reaction in a homogeneous medium, the viscosity of the solution did not increase obviously, and the product was stable during the process of leaving the solution, and no aggregation or precipitation phenomenon occurred. 50% HMF and 80% HFM aqueous solutions were shown to have the highest dissolving power for sodium hyaluronate, and it was shown that a high quaternary ammonium salt ionization reaction can be obtained in this homogeneous system. In this reaction system, the local adsorption of hyaluronic acid solid particles to GTA can be reduced, the reaction rate can be increased, the uniform reaction of hydroxymethyl on the unit molecule can be promoted, the side reaction of GTA can be reduced, and the amount of GTA used can be significantly reduced.
[0034] Sodium hyaluronate (HA) and 2,3-epoxypropyltrimethylammonium chloride (GTA) were subjected to ionization grafting reaction in a homogeneous aqueous solution of formamide (HMF), and a basic catalyst was added to the system to provide a slightly basic environment and promote the coupling reaction of GTA and HA. The inorganic base includes NaOH, KOH, NaCO3, K2CO3, CH3COONa, CH3COOK, and NaHCO3. In the actual reaction, NaOH is preferred, and the amount of NaOH base used is 0.01, 0.02, 0.04, 0.08, 0.12, 0.14, 0.16, and 0.18 mol / HA relative to the average unit total mole number. During the reaction, the pH was adjusted to 7.0-7.5 with a base, and the mixture was stirred and heated until the reaction was completed. When the mixture of HA:HMF-H2O = 1:40 (mass / volume, kg / L) was cationized with HA:GTA = 1:2 (molar ratio), the NaOH molar ratio was 0.01-0.18 mol / HA, and the reaction temperature was 65 °C. At the start of the reaction, the rate of both the main reaction (cationization of HA) and the side reaction of GTA increased with increasing NaOH content in the reaction mixture. If the NaOH content in the reaction mixture is in the range of 0.02-0.08 mol / HA, GTA does not cause a side reaction in the early stage, and if the NaOH content exceeds 0.18 mol / HA, both the main reaction and the side reaction of GTA proceed from the first few minutes. In addition, it was observed through experiments that the rate constant (km) of the main reaction increased by more than 25 times when the catalyst usage amount was increased from 0.02 to 0.12 mol / HA. The NaOH content exceeded 0.08 mol / HA when an increase in the side reaction rate constant was observed. At this level of NaOH, the main reaction proceeds faster than the side reaction. It was concluded that the efficiency of GTA usage is optimal when the NaOH content in the reaction mixture is 0.08 mol / HA.
Claims
1. The method includes the steps of adding a homogeneous solvent and sodium hyaluronate solid to a container, heating the mixture until the mixture is dissolved in a homogeneous system, adding an aqueous solution of 2,3-epoxypropyltrimethylammonium chloride, and then adding a basic catalyst. The mixture is stirred at a predetermined temperature to carry out a grafting reaction, thereby obtaining a graft product in which 2,3-epoxypropyltrimethylammonium chloride is grafted onto the oxygen atom of the hydroxymethyl group of sodium hyaluronate; The homogeneous solvent is a mixture of HMF and H 2 O, HMF-H 2 O, The method for producing and purifying sodium hyaluronate cationic quaternary ammonium salt in a homogeneous medium, wherein HMF in said HMF-H 2 O is 50% to 80% by volume of water.
2. The method for preparing and purifying sodium hyaluronate cationic quaternary ammonium salt in a homogeneous medium according to claim 1, characterized in that the molar ratio of said sodium hyaluronate solid to 2,3-epoxypropyltrimethylammonium chloride is 1:0.5-10, preferably 1:
2.
3. The method for preparing and purifying sodium hyaluronate cationic quaternary ammonium salt in a homogeneous medium according to claim 1, characterized in that the predetermined temperature is 40-80°C, and the reaction time is at least 0.5h.
4. The basic catalyst is NaOH, KOH, Na 2 CO 3 , K 2 CO 3 , C.H. 3 COONa, C.H. 3 COOK, K.H.C.O. 3 , NaHCO 3 The method for producing and purifying sodium hyaluronate cationic quaternary ammonium salt in a homogeneous medium according to claim 1, characterized in that at least one of the following is used:
5. After the graft reaction is completed, the reaction system is subjected to alcohol precipitation to obtain a mixed solution A containing a precipitate, and the separated precipitate is sufficiently dissolved in water to obtain a liquid material; Adding 1-5% purified salt NaCl or KCl solution to the liquid material, stirring to dissolve thoroughly, and adjusting the pH value of the liquid material to 6.0-7.5; performing a secondary alcohol precipitation, adding water to the separated precipitate to further dissolve it, and then performing a further alcohol precipitation to obtain a precipitate; The method for preparing and purifying sodium hyaluronate cationic quaternary ammonium salt in homogeneous medium according to claim 1, further comprising the steps of: washing with alcohol, dehydrating and drying the precipitate to obtain the final product.
6. The method for preparing and purifying cationic quaternary ammonium salt of sodium hyaluronate in homogeneous medium according to claim 5, characterized in that in alcohol precipitation, the volume ratio of liquid material and ethanol is 1:1-10, and when precipitate is added with water to dissolve, the mass volume ratio of precipitate and water is 1:5-50.
Citation Information
Patent Citations
Method for preparing cationic hyaluronate by semidry process
CN111560086A
cosmetic
JP2013040140A
Cationized hyaluronic acid and / or salt thereof, method for producing the same, and hair modifying agent, cuticle repairing agent, skin modifying agent and cosmetic preparation each using the same
WO2008133267A1
Method for manufacturing purified hyaluronic acids
WO2011070948A1
